BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16598676)

  • 1. Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers.
    Saba SR; Vesely DL
    Histol Histopathol; 2006 Jul; 21(7):775-83. PubMed ID: 16598676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of atrial natriuretic peptide, vessel dilator, long-acting natriuretic peptide, and kaliuretic peptide in human pancreatic adenocarcinomas.
    Saba SR; Garces AH; Clark LC; Soto J; Gower WR; Vesely DL
    J Histochem Cytochem; 2005 Aug; 53(8):989-95. PubMed ID: 15879575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.
    Vesely DL
    Curr Pharm Des; 2010; 16(9):1159-66. PubMed ID: 20030620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptides: anticancer agents.
    Vesely DL
    J Investig Med; 2005 Nov; 53(7):360-5. PubMed ID: 16297362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
    Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
    In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic approach for cancer using four cardiovascular hormones.
    Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
    Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
    Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
    Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and renal hormones: anticancer effects in vitro and in vivo.
    Vesely DL
    J Investig Med; 2009 Jan; 57(1):22-8. PubMed ID: 19092678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
    Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
    In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
    Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
    Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
    Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
    Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central role of β-catenin in anticancer effects of cardiac hormones.
    Skelton WP; Skelton M; Vesely DL
    Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
    Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
    Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anticancer agents: hormones made within the heart.
    Vesely DL
    Anticancer Res; 2012 Jul; 32(7):2515-21. PubMed ID: 22753708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
    Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
    Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways.
    Vesely DL
    Cancers (Basel); 2011 Mar; 3(1):1182-94. PubMed ID: 24212659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
    Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
    Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family of peptides synthesized in the human body have anticancer effects.
    Vesely DL
    Anticancer Res; 2014 Apr; 34(4):1459-66. PubMed ID: 24692673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.